Bridging Nature, Science & Red Light Technology in Gut-Brain Health

A One-Line Rebellion Against The Wellness Machine

At the Biohacker Summit in Helsinki, Finland, on Wednesday 3 July 2024, Sarah Turner opened with a line that cut clean through the industry she helps lead: “Yes, I am the CEO of a red light therapy company, and I'm here to tell you that you don't need red light therapy.”

The Case For Going Backward To Move Forward

Turner, a biohacker, light expert, CEO and co-founder of CeraThrive, and co-host of the Rebel Scientist podcast, used her presentation, Bridging Nature, Science & Red Light Technology in Gut-Brain Health, to make an argument that felt both old-fashioned and quietly radical. Human health, she said, had drifted too far from the rhythms that once shaped it.

Before electric bulbs, sealed offices and glowing screens, people rose and slept with the sun, absorbed longer wavelengths of red and near-infrared light at dawn and dusk, and lived in far closer contact with the natural world. Modern life, by contrast, had become profoundly indoor. In Turner’s telling, that shift mattered. “We need to go back to our mammalian biology and start thinking about these technologies,” she said.

Her point was not anti-technology. It was anti-reductionism. If red light tools were to work well, she argued, they should borrow from nature rather than attempt to overpower it.

Why Light Still Matters To The Body

Turner sketched the now familiar scientific case for red light therapy. Light in the red and near-infrared range interacts with mitochondria, the cell’s energy-producing structures, helping support ATP production, cell signalling and blood flow through nitric oxide release.

Yet she resisted the temptation to let that mechanism become a doctrine. Much of the industry, she suggested, had become fixated on a narrow set of wavelengths and a single biochemical target, cytochrome c oxidase, because that is where much of the published evidence sits. Useful, yes. Complete, no.

The body, she reminded the audience, is not a collection of isolated switches. It is an interconnected system layered across scales, from molecular to systemic. “We are systems within systems, so our bodies are totally connected,” Turner said.

Beyond A Narrow Beam

One of the sharpest ideas in the talk was that a broader spectrum of light may be more biologically faithful, and possibly more useful, than highly narrow, highly standardised devices.

Sunlight does not arrive as a single therapeutic frequency. It arrives as a spectrum. Turner suggested that longer wavelengths, including those often overlooked, may matter because of their interaction with water in the body, particularly what researchers have described as structured or fourth-phase water.

This was where her talk moved into more exploratory terrain. Drawing on work by scientists such as Mae-Wan Ho and Gerald Pollack, Turner argued that light may alter the structure and behaviour of water near cell surfaces, with potential downstream effects on protein folding, cellular efficiency and brain function. In a field often eager for certainty, she argued for room to investigate what remains poorly understood.

“Embrace more of how nature works, how things work at different scales, potentially have a broad range of power, a broad range of wavelengths,” she said.

The Problem With Treating Wellness Like A Drug Trial

Turner’s critique was not of science itself, but of a scientific culture that can become too rigid when applied to emerging health technologies. With a background in pharmaceuticals and training in clinical neuroscience, psychological sciences, nutritional medicine and photobiomodulation, she spoke as someone familiar with both evidence and its limits.

Consumers, she noted, often ask for the best wavelength, the strongest output, the ideal dose, as though the body were a machine waiting for one precise setting. But the data, she said, does not support such simplistic thinking. Therapeutic effects appear across a wide range of power outputs and dosing patterns.

The instinct to assume that more power means better results may satisfy a biohacker appetite for intensity. Turner suggested something subtler: lower to medium power, variability, and enough flexibility for the body to respond in its own way.

Mimicking Nature, Not A Metronome

Perhaps the most compelling thread in the presentation was Turner’s insistence that nature rarely behaves in rigid repetition. If the body thrives on variation, then therapy devices should not deliver perfectly repetitive pulsing as though biological systems were metronomes.

She linked this to broader ideas of adaptability, invoking the logic of heart rate variability and circadian rhythms. Biological resilience, she implied, often lies in variation, not mechanical regularity. Devices that use variable pulsing schedules may therefore be more in tune with how the body recognises and uses signals.

It was an elegant inversion of the usual sales pitch. The more sophisticated the device, in Turner’s view, the less it should behave like a machine and the more it should resemble the fluctuating intelligence of nature.

The Gut-Brain Axis As A Whole-Body Story

Although the session was framed around gut-brain health, Turner treated the phrase not as a niche topic but as an organising principle. Rather than target a symptom in isolation, she argued for treating the body as a network, where gut health, brain function, circulation, inflammation and energy production continuously shape one another.

This was particularly important, she said, in brain wellness. Light directed solely at the head may miss the wider biological terrain in which cognition, fatigue and mood are embedded. The gut, in her framing, was not secondary but foundational, the “first brain” rather than merely the second.

That systemic approach, she suggested, may explain why interventions aimed at the gut-brain axis can produce changes that seem to exceed the original complaint.

A Case Study In Systemic Change

To illustrate the point, Turner presented a case study involving a user named Seb, who had been diagnosed with motor neurone disease in 2016 and had been using her gut-brain system for around six months. According to the testimony played to the audience, he reported improvements in energy, reduced headaches, a clearing of brain fog and less muscle tension. Most strikingly, he said he had recently managed to take a few steps with a walking aid after years of being wheelchair-bound.

Anecdote is not evidence, and Turner did not present it as a clinical trial. But in a room full of people interested in human performance and frontier therapies, the testimonial underscored her central theme: when health is approached systemically, changes may emerge across multiple domains at once.

A Strange, Persuasive Humility

What lingered after Turner’s session at the Biohacker Summit was not a product pitch, though her company and devices were clearly part of the discussion. It was the odd humility of her core message. Red light technology, she argued, may be useful precisely because modern life has become so unnatural. The ideal solution is not another device, but a return to sunlight, outdoor living, seasonal rhythms and biological common sense.

That is not a convenient message for an industry built on optimisation. It is, however, a powerful one.

“Effortlessly bridges the gap between nature and cutting edge science to optimize human performance,” read one line associated with the session. In Helsinki, Sarah Turner gave that promise a more grounded meaning. The future of health technology, she suggested, may depend less on discovering how to dominate biology and more on remembering how to listen to it.

Frequently asked questions

Why did a red light CEO say you don't need red light?

Sarah Turner, chief executive and co-founder of CeraThrive, opened with exactly that line. Her argument was that human health had drifted too far from the rhythms that once shaped it, and that daylight and natural cycles come before any device.

How does red light interact with the body?

Turner sketched the standard case: light in the red and near-infrared range interacts with mitochondria, supporting ATP production, cell signalling and blood flow through nitric oxide release. She resisted letting that mechanism harden into doctrine.

Is a narrow wavelength better than a broad spectrum?

Turner argued the opposite may be true. Sunlight does not arrive as a single therapeutic frequency but as a spectrum, and she suggested that longer wavelengths often overlooked by standardised devices may matter because of how they interact with water in the body.

About the event

This recap is part of the Biohacker Summit 2024 Helsinki series, recorded in Helsinki on 2 and 3 July 2024. Read the summary of the whole event or join the next edition, HOLOLIFE Summit 2026 Amsterdam, on 14 and 15 November 2026.